Literature DB >> 18045910

The Down syndrome critical region protein RCAN1 regulates long-term potentiation and memory via inhibition of phosphatase signaling.

Charles A Hoeffer1, Asim Dey, Nita Sachan, Helen Wong, Richard J Patterson, John M Shelton, James A Richardson, Eric Klann, Beverly A Rothermel.   

Abstract

Regulator of calcineurin 1 (RCAN1/MCIP1/DSCR1) regulates the calmodulin-dependent phosphatase calcineurin. Because it is located on human chromosome 21, RCAN1 has been postulated to contribute to mental retardation in Down syndrome and has been reported to be associated with neuronal degeneration in Alzheimer's disease. The studies herein are the first to assess the role of RCAN1 in memory and synaptic plasticity by examining the behavioral and electrophysiological properties of RCAN1 knock-out mice. These mice exhibit deficits in spatial learning and memory, reduced associative cued memory, and impaired late-phase long-term potentiation (L-LTP), phenotypes similar to those of transgenic mice with increased calcineurin activity. Consistent with this, the RCAN1 knock-out mice display increased enzymatic calcineurin activity, increased abundance of a cleaved calcineurin fragment, and decreased phosphorylation of the calcineurin substrate dopamine and cAMP-regulated phosphoprotein-32. We propose a model in which RCAN1 plays a positive role in L-LTP and memory by constraining phosphatase signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045910      PMCID: PMC6673398          DOI: 10.1523/JNEUROSCI.3974-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  The RCAN carboxyl end mediates calcineurin docking-dependent inhibition via a site that dictates binding to substrates and regulators.

Authors:  Sara Martínez-Martínez; Lali Genescà; Antonio Rodríguez; Alicia Raya; Eulàlia Salichs; Felipe Were; María Dolores López-Maderuelo; Juan Miguel Redondo; Susana de la Luna
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-30       Impact factor: 11.205

2.  1H, 15N, and 13C chemical shift assignments of the regulatory domain of human calcineurin.

Authors:  Dinesh K Yadav; Sri Ramya Tata; John Hunt; Erik C Cook; Trevor P Creamer; Nicholas C Fitzkee
Journal:  Biomol NMR Assign       Date:  2017-08-12       Impact factor: 0.746

Review 3.  Aberrant expression of RCAN1 in Alzheimer's pathogenesis: a new molecular mechanism and a novel drug target.

Authors:  Yili Wu; Philip T T Ly; Weihong Song
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

4.  Calcineurin Dysregulation Underlies Spinal Cord Injury-Induced K+ Channel Dysfunction in DRG Neurons.

Authors:  Benjamin M Zemel; Tanziyah Muqeem; Eric V Brown; Miguel Goulão; Mark W Urban; Stephen R Tymanskyj; Angelo C Lepore; Manuel Covarrubias
Journal:  J Neurosci       Date:  2017-07-27       Impact factor: 6.167

5.  Structural basis for activation of calcineurin by calmodulin.

Authors:  Julie Rumi-Masante; Farai I Rusinga; Terrence E Lester; Tori B Dunlap; Todd D Williams; A Keith Dunker; David D Weis; Trevor P Creamer
Journal:  J Mol Biol       Date:  2011-11-12       Impact factor: 5.469

6.  The CCAAT/enhancer binding protein beta (C/EBPbeta) cooperates with NFAT to control expression of the calcineurin regulatory protein RCAN1-4.

Authors:  Misook Oh; Asim Dey; Robert D Gerard; Joseph A Hill; Beverly A Rothermel
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

7.  Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation.

Authors:  Min-Su Jung; Jung-Hwa Park; Young Shin Ryu; Sun-Hee Choi; Song-Hee Yoon; Mi-Yang Kwen; Ji Youn Oh; Woo-Joo Song; Sul-Hee Chung
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

8.  Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro.

Authors:  Gennady Ermak; Karl J Hench; Kevin T Chang; Sean Sachdev; Kelvin J A Davies
Journal:  J Biol Chem       Date:  2009-03-06       Impact factor: 5.157

9.  Domain architecture of the regulators of calcineurin (RCANs) and identification of a divergent RCAN in yeast.

Authors:  Sohum Mehta; Huiming Li; Patrick G Hogan; Kyle W Cunningham
Journal:  Mol Cell Biol       Date:  2009-03-09       Impact factor: 4.272

10.  Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior.

Authors:  Charles A Hoeffer; Wei Tang; Helen Wong; Arturo Santillan; Richard J Patterson; Luis A Martinez; Maria V Tejada-Simon; Richard Paylor; Susan L Hamilton; Eric Klann
Journal:  Neuron       Date:  2008-12-10       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.